Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 67

1.

Distribution of CYP2D6 alleles and phenotypes in the Brazilian population.

Friedrich DC, Genro JP, Sortica VA, Suarez-Kurtz G, de Moraes ME, Pena SD, dos Santos AK, Romano-Silva MA, Hutz MH.

PLoS One. 2014 Oct 20;9(10):e110691. doi: 10.1371/journal.pone.0110691. eCollection 2014.

PMID:
25329392
[PubMed - in process]
Free PMC Article
2.

Determination of CYP2D6 *3, *4, and *10 frequency in women with breast cancer in São Luís, Brazil, and its association with prognostic factors and disease-free survival.

Martins DM, Vidal FC, Souza RD, Brusaca SA, Brito LM.

Braz J Med Biol Res. 2014 Nov;47(11):1008-15. Epub 2014 Sep 5.

PMID:
25296365
[PubMed - in process]
Free PMC Article
3.

Drug-induced QT interval prolongation: mechanisms and clinical management.

Nachimuthu S, Assar MD, Schussler JM.

Ther Adv Drug Saf. 2012 Oct;3(5):241-53. doi: 10.1177/2042098612454283. Review.

PMID:
25083239
[PubMed]
Free PMC Article
4.

Severe cholestatic jaundice after a single administration of ajmaline; a case report and review of the literature.

Mullish BH, Fofaria RK, Smith BC, Lloyd K, Lloyd J, Goldin RD, Dhar A.

BMC Gastroenterol. 2014 Apr 2;14:60. doi: 10.1186/1471-230X-14-60. Review.

PMID:
24694003
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy.

Preissner SC, Hoffmann MF, Preissner R, Dunkel M, Gewiess A, Preissner S.

PLoS One. 2013 Dec 10;8(12):e82562. doi: 10.1371/journal.pone.0082562. eCollection 2013. Review.

PMID:
24340040
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Pharmacogenetics and individualizing drug treatment during pregnancy.

Haas DM.

Pharmacogenomics. 2014 Jan;15(1):69-78. doi: 10.2217/pgs.13.228. Review.

PMID:
24329192
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Clinical efficacy and safety of fluoxetine in generalized anxiety disorder in Chinese patients.

Zou C, Ding X, Flaherty JH, Dong B.

Neuropsychiatr Dis Treat. 2013;9:1661-70. doi: 10.2147/NDT.S38899. Epub 2013 Nov 1. Review.

PMID:
24204151
[PubMed]
Free PMC Article
8.

Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study.

Copson E, Maishman T, Gerty S, Eccles B, Stanton L, Cutress RI, Altman DG, Durcan L, Simmonds P, Jones L, Tapper W; POSH study steering group, Eccles D.

Br J Cancer. 2014 Jan 7;110(1):230-41. doi: 10.1038/bjc.2013.650. Epub 2013 Oct 22.

PMID:
24149174
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Pharmacogenetic testing: Current Evidence of Clinical Utility.

Moaddeb J, Haga SB.

Ther Adv Drug Saf. 2013 Aug 1;4(4):155-169.

PMID:
24020014
[PubMed]
Free PMC Article
10.

Concordance between CYP2D6 genotypes obtained from tumor-derived and germline DNA.

Rae JM, Regan MM, Thibert JN, Gersch C, Thomas D, Leyland-Jones B, Viale G, Pusztai L, Hayes DF, Skaar T, Van Poznak C.

J Natl Cancer Inst. 2013 Sep 4;105(17):1332-4. doi: 10.1093/jnci/djt204. Epub 2013 Aug 19.

PMID:
23958736
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The metabolism of primaquine to its active metabolite is dependent on CYP 2D6.

Pybus BS, Marcsisin SR, Jin X, Deye G, Sousa JC, Li Q, Caridha D, Zeng Q, Reichard GA, Ockenhouse C, Bennett J, Walker LA, Ohrt C, Melendez V.

Malar J. 2013 Jun 20;12:212. doi: 10.1186/1475-2875-12-212.

PMID:
23782898
[PubMed - in process]
Free PMC Article
12.

Influence of CYP2D6 polymorphisms on serum levels of tamoxifen metabolites in Spanish women with breast cancer.

Zafra-Ceres M, de Haro T, Farez-Vidal E, Blancas I, Bandres F, de Dueñas EM, Ochoa-Aranda E, Gomez-Capilla JA, Gomez-Llorente C.

Int J Med Sci. 2013 May 27;10(7):932-7. doi: 10.7150/ijms.5708. Print 2013.

PMID:
23781139
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Genetic analysis of primaquine tolerance in a patient with relapsing vivax malaria.

Bright AT, Alenazi T, Shokoples S, Tarning J, Paganotti GM, White NJ, Houston S, Winzeler EA, Yanow SK.

Emerg Infect Dis. 2013 May;19(5):802-5. doi: 10.3201/eid1905.121852.

PMID:
23648098
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.

Crist RC, Clarke TK, Ang A, Ambrose-Lanci LM, Lohoff FW, Saxon AJ, Ling W, Hillhouse MP, Bruce RD, Woody G, Berrettini WH.

Neuropsychopharmacology. 2013 Sep;38(10):2003-10. doi: 10.1038/npp.2013.99. Epub 2013 Apr 23. Erratum in: Neuropsychopharmacology. 2014 Mar;39(4):1039.

PMID:
23612435
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Applications of CYP450 testing in the clinical setting.

Samer CF, Lorenzini KI, Rollason V, Daali Y, Desmeules JA.

Mol Diagn Ther. 2013 Jun;17(3):165-84. doi: 10.1007/s40291-013-0028-5. Review.

PMID:
23588782
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Pharmacogenetics and pharmacogenomics in rheumatology.

Szekanecz Z, Meskó B, Poliska S, Váncsa A, Szamosi S, Végh E, Simkovics E, Laki J, Kurkó J, Besenyei T, Mikecz K, Glant TT, Nagy L.

Immunol Res. 2013 Jul;56(2-3):325-33. doi: 10.1007/s12026-013-8405-z. Review.

PMID:
23564183
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

CYP2D6 genotypes, endoxifen levels, and disease recurrence in 224 Filipino and Vietnamese women receiving adjuvant tamoxifen for operable breast cancer.

Love RR, Desta Z, Flockhart D, Skaar T, Ogburn ET, Ramamoorthy A, Uy GB, Laudico AV, Van Dinh N, Quang le H, Van To T, Young GS, Hade E, Jarjoura D.

Springerplus. 2013 Dec;2(1):52. doi: 10.1186/2193-1801-2-52. Epub 2013 Feb 15.

PMID:
23476897
[PubMed]
Free PMC Article
18.

Role of cytochrome P450 genotype in the steps toward personalized drug therapy.

Cavallari LH, Jeong H, Bress A.

Pharmgenomics Pers Med. 2011;4:123-36. doi: 10.2147/PGPM.S15497. Epub 2011 Nov 7.

PMID:
23226058
[PubMed]
Free PMC Article
19.

Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy.

Li J, Bluth MH.

Pharmgenomics Pers Med. 2011;4:11-33. doi: 10.2147/PGPM.S18861. Epub 2011 Apr 1.

PMID:
23226051
[PubMed]
Free PMC Article
20.

Reduced CYP2D6 function is associated with gefitinib-induced rash in patients with non-small cell lung cancer.

Suzumura T, Kimura T, Kudoh S, Umekawa K, Nagata M, Matsuura K, Tanaka H, Mitsuoka S, Yoshimura N, Kira Y, Nakai T, Hirata K.

BMC Cancer. 2012 Dec 4;12:568. doi: 10.1186/1471-2407-12-568.

PMID:
23207012
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk